1-6 of 503 Activities
This live Engage the Experts webcast from CME Outfitters will bring these principles to life through practical, real-world clinical decision-making. Through expert discussion, brief patient cases, patient perspectives, decision point polling, and live Q&A, learners will apply biopsychosocial assessment, validated pain tools, multimodal treatment, opioid risk assessment, safe prescribing and counseling, DSM-5 criteria for OUD, and evidence-based, non-stigmatizing communication. Patient experience checkpoints will reinforce shared decision-making and what patients need to understand at key clinical decisions.
This CME Outfitters livestream symposium equips family medicine clinicians with practical, workflow-ready strategies to recognize and manage CKM disease as a unified continuum. In this activity, participants will explore the shared pathophysiology linking cardiovascular, kidney, and metabolic disease; sharpen their use of combined eGFR and uACR screening and KDIGO risk stratification; and apply guideline-aligned, patient-centered approaches that include shared decision-making and multidisciplinary coordination to optimize cardiorenal protection across overlapping comorbidities.
In this case-based CME Outfitters live webcast, expert faculty will guide learners through real-world diagnostic and treatment decision points that translate biomarker-informed IIM classification into clinical practice, linking subtype recognition to further diagnostic evaluation, targeted comorbidity assessment, multidisciplinary care, and current and emerging steroid-sparing treatment strategies. Patient perspectives on function, treatment burden, quality of life, and personal goals will be integrated into these decisions, while investigational FcRn inhibition is considered within a fair and balanced therapeutic landscape.
Obesity is transforming the landscape of inflammatory bowel disease (IBD), shaping disease activity, treatment response, and long-term prognosis. As evidence reveals the impact of excess weight on biologic and JAK inhibitor effectiveness, emerging anti-obesity therapies, including GLP-1 receptor agonists, are creating new opportunities to improve patient outcomes. To stay ahead of this rapidly evolving field, gastroenterologists and multidisciplinary care teams need timely, evidence-based education to confidently integrate obesity management into personalized, stigma-free IBD care.
This fast-paced and highly interactive livestream CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will compare their treatment choices to those of leading experts, peers in the room, providers in the community, patients themselves, and even AI-based insights. Learners will see how the immunometabolic impact of visceral and mesenteric adiposity on disease activity, treatment response, and surgical risk translates into practice, what doesn’t translate, and why. Designed to challenge assumptions and sharpen strategy, this immersive format empowers clinicians to immediately apply validated adiposity assessment methods, confidently integrate GLP-1 RAs into individualized treatment planning, and deliver patient-centered IBD care.
This event is neither sponsored by nor endorsed by ACG.
This fast-paced and highly interactive live CaseWise™ webcast from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will explore key clinical challenges to help sharpen diagnostic confidence, individualize treatment, and help patients achieve better long-term outcomes.
In the third activity of this CMEO podcast series, expert faculty will assist learners to recognize common and clinically significant extraintestinal manifestations associated with IBD, incorporate practical screening approaches into routine clinical workflows, and implement multidisciplinary care strategies for patients with systemic disease involvement.
